,Set,NGenes,Direction,PValue,FDR
1,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,3.9507647530164e-06,0.00324752862697948
2,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.000251324732202034,0.0814103564995771
3,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.000298696294832033,0.0814103564995771
4,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.000465151175987548,0.0814103564995771
5,WP_IRON_METABOLISM_DISORDERS,13,Up,0.000495196815690858,0.0814103564995771
6,WP_PROSTAGLANDIN_SIGNALING,23,Down,0.000666850268190472,0.0913584867420947
7,WP_NUCLEOTIDE_GPCRS,5,Down,0.000965705669191496,0.11340143715363
8,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.00140572467297731,0.144438210148419
9,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.00244997307782317,0.223764207774516
10,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,29,Down,0.00346082356145118,0.284479696751287
11,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Down,0.00508301871095564,0.302302403916815
12,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,16,Down,0.0051034064065388,0.302302403916815
13,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,33,Down,0.00527988854162386,0.302302403916815
14,WP_MONOAMINE_GPCRS,3,Down,0.00539101080499775,0.302302403916815
15,WP_IRON_METABOLISM_IN_PLACENTA,10,Up,0.00586021779454513,0.302302403916815
16,WP_INTEGRINMEDIATED_CELL_ADHESION,71,Down,0.00590838226483587,0.302302403916815
17,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,24,Down,0.00657765733335339,0.302302403916815
18,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.00661976066971127,0.302302403916815
19,WP_IL3_SIGNALING,46,Down,0.00707459996520582,0.306069535336799
20,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.00761958689075131,0.313165021209879
21,WP_PURINERGIC_SIGNALING,14,Down,0.00896349625989724,0.343860908674995
22,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.00920309001319938,0.343860908674995
23,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,79,Down,0.0103794630340039,0.37095298321527
24,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,34,Down,0.0115528991680706,0.395305561022723
25,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.0120226752135865,0.395305561022723
26,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Down,0.0138407935682741,0.437582012043127
27,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,8,Down,0.0153910701182664,0.468572579156111
28,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.016162596689977,0.474487659970039
29,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.0197091773392474,0.553145300108633
30,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.0201877846754976,0.553145300108633
31,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,52,Down,0.0217699645324989,0.576616234094036
32,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,22,Down,0.0224473473126632,0.576616234094036
33,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,16,Up,0.0235491258514492,0.586587316663372
34,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,20,Up,0.0245196541714206,0.592798697909051
35,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.0252644616626694,0.593353928191837
36,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,9,Down,0.0269938713006975,0.615517484190399
37,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.028333947251346,0.615517484190399
38,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,25,Down,0.0295785078216122,0.615517484190399
39,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.029756900583103,0.615517484190399
40,WP_ANGIOGENESIS,14,Up,0.0299521890116982,0.615517484190399
41,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,36,Down,0.0338368929221505,0.659087353959566
42,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,56,Down,0.0343208992756311,0.659087353959566
43,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,40,Down,0.0344778056207559,0.659087353959566
44,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Down,0.035942423790131,0.661824337409916
45,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.0379631750998589,0.661824337409916
46,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Down,0.0383833587318761,0.661824337409916
47,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.0384457941336523,0.661824337409916
48,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.0386466766370754,0.661824337409916
49,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.040981342845783,0.665783123885393
50,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,14,Down,0.0410671894224446,0.665783123885393
51,WP_COMPLEMENT_ACTIVATION,13,Up,0.0413077120658821,0.665783123885393
52,WP_MALE_INFERTILITY,69,Up,0.043007200056932,0.677128705126205
53,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Down,0.0436591500872127,0.677128705126205
54,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Up,0.0467789151891329,0.712079042323468
55,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.0493597334560211,0.722855854492377
56,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.0494740612110222,0.722855854492377
57,WP_FERROPTOSIS,51,Up,0.0507285890210634,0.722855854492377
58,WP_VALPROIC_ACID_PATHWAY,8,Down,0.0559999702060984,0.722855854492377
59,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.0565259055621569,0.722855854492377
60,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,40,Down,0.0588101445101232,0.722855854492377
61,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.059144972897398,0.722855854492377
62,WP_IL1_SIGNALING,53,Down,0.0605101046805695,0.722855854492377
63,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Down,0.060617895809247,0.722855854492377
64,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.0614883543955035,0.722855854492377
65,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,31,Down,0.0618893581168065,0.722855854492377
66,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.0619722701762685,0.722855854492377
67,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Down,0.0628445511989928,0.722855854492377
68,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,16,Down,0.0631321730629848,0.722855854492377
69,WP_CHEMOKINE_SIGNALING,109,Down,0.0645653707466102,0.722855854492377
70,WP_TNFALPHA_SIGNALING,85,Down,0.0646287216749992,0.722855854492377
71,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,13,Down,0.0662350808836037,0.722855854492377
72,WP_ZINC_HOMEOSTASIS,24,Up,0.0670340111292946,0.722855854492377
73,WP_TLR4_SIGNALING_AND_TOLERANCE,27,Down,0.067317246676335,0.722855854492377
74,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Down,0.0681037966367608,0.722855854492377
75,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Down,0.0692758475760936,0.722855854492377
76,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Up,0.0701211562815827,0.722855854492377
77,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Down,0.0707126870623132,0.722855854492377
78,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.0725586765442525,0.722855854492377
79,WP_G1_TO_S_CELL_CYCLE_CONTROL,53,Up,0.07342734085555,0.722855854492377
80,WP_CCL18_SIGNALING,21,Up,0.0740032040516607,0.722855854492377
81,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,15,Down,0.0741317271815521,0.722855854492377
82,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Down,0.0751826992665215,0.722855854492377
83,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.0767342498113135,0.722855854492377
84,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.0770911542461157,0.722855854492377
85,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.0779137540383568,0.722855854492377
86,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.0779289855660233,0.722855854492377
87,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.0789825710631745,0.722855854492377
88,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,21,Down,0.0791935052499174,0.722855854492377
89,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.0797141551175511,0.722855854492377
90,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Up,0.0827296463211926,0.722855854492377
91,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.0829254344358528,0.722855854492377
92,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.0832479013093443,0.722855854492377
93,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,24,Up,0.0854797856962467,0.722855854492377
94,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Down,0.0855629535677698,0.722855854492377
95,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.0869221593865385,0.722855854492377
96,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.087443315388974,0.722855854492377
97,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,8,Up,0.0877668048274917,0.722855854492377
98,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.0877891113646838,0.722855854492377
99,WP_MAPK_SIGNALING,163,Down,0.0877994804022268,0.722855854492377
100,WP_MEASLES_VIRUS_INFECTION,102,Down,0.088522204140974,0.722855854492377
101,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,16,Down,0.0891005264541464,0.722855854492377
102,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.0905659117840625,0.722855854492377
103,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Up,0.0905768284826214,0.722855854492377
104,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.0919466055215344,0.726731824410589
105,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.0945411715788818,0.730870909232929
106,WP_BLOOD_CLOTTING_CASCADE,7,Down,0.0947138727812536,0.730870909232929
107,WP_NRXN1_DELETION_SYNDROME,2,Up,0.0951376974305637,0.730870909232929
108,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.0972196802928483,0.734344829163154
109,WP_DRAVET_SYNDROME,13,Up,0.0976692470628824,0.734344829163154
110,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,21,Down,0.0995353423728615,0.734344829163154
111,WP_RAC1PAK1P38MMP2_PATHWAY,50,Down,0.101203734114233,0.734344829163154
112,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,2,Down,0.102714329156483,0.734344829163154
113,WP_NEPHROGENESIS,4,Down,0.102743822578929,0.734344829163154
114,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Up,0.103672829179756,0.734344829163154
115,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,10,Up,0.105381604820633,0.734344829163154
116,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.106245884621463,0.734344829163154
117,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.107450924501799,0.734344829163154
118,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.107701624359839,0.734344829163154
119,WP_OREXIN_RECEPTOR_PATHWAY,120,Down,0.109805436963817,0.734344829163154
120,WP_CYTOSINE_METHYLATION,7,Up,0.110536628946743,0.734344829163154
121,WP_CREATINE_PATHWAY,2,Down,0.110571311223659,0.734344829163154
122,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Down,0.111407911628169,0.734344829163154
123,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.111482274861591,0.734344829163154
124,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.111656237022673,0.734344829163154
125,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,14,Down,0.11170077606302,0.734344829163154
126,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.112775601457704,0.734344829163154
127,WP_IDO_METABOLIC_PATHWAY,8,Down,0.113457169469246,0.734344829163154
128,WP_RANKLRANK_SIGNALING,48,Down,0.115382764452316,0.73765225429198
129,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.115762945016625,0.73765225429198
130,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.121057761908718,0.755061668767441
131,WP_HEME_BIOSYNTHESIS,8,Up,0.121057761908718,0.755061668767441
132,WP_OXIDATIVE_DAMAGE_RESPONSE,35,Up,0.121250778926158,0.755061668767441
133,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.12519024139136,0.766425580184665
134,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.126615936906209,0.766425580184665
135,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,30,Down,0.127396682531051,0.766425580184665
136,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Down,0.127796982164202,0.766425580184665
137,WP_NPHP1_DELETION_SYNDROME,10,Down,0.128042575725661,0.766425580184665
138,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.12993050707721,0.766425580184665
139,WP_METASTATIC_BRAIN_TUMOR,6,Up,0.129986751191408,0.766425580184665
140,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.131170039258787,0.766425580184665
141,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Up,0.131467161564523,0.766425580184665
142,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.134562714044854,0.778947541865279
143,WP_13Q1212_COPY_NUMBER_VARIATION,21,Down,0.137319129567679,0.787567050000861
144,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.138018026444556,0.787567050000861
145,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.138926061131539,0.787567050000861
146,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.145393307371584,0.804413872866772
147,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Up,0.145960268071158,0.804413872866772
148,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.148782905012521,0.804413872866772
149,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.151460507369509,0.804413872866772
150,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.152756193108724,0.804413872866772
151,WP_OPIOID_RECEPTOR_PATHWAYS,26,Down,0.15293271939128,0.804413872866772
152,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.153289252602245,0.804413872866772
153,WP_NEURAL_CREST_DIFFERENTIATION,40,Up,0.154719349159283,0.804413872866772
154,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.154743787402083,0.804413872866772
155,WP_NOTCH_SIGNALING_WP268,36,Down,0.155494997771775,0.804413872866772
156,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.155929953863804,0.804413872866772
157,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.156826565689353,0.804413872866772
158,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,12,Down,0.157368897691083,0.804413872866772
159,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Down,0.158155248056702,0.804413872866772
160,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Down,0.15841149442514,0.804413872866772
161,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.161520058814913,0.804413872866772
162,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.161726522109575,0.804413872866772
163,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,12,Up,0.163178708396848,0.804413872866772
164,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.167756205172609,0.804413872866772
165,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Down,0.169908376191849,0.804413872866772
166,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.173435629109856,0.804413872866772
167,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Up,0.173570782670211,0.804413872866772
168,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.173733088254879,0.804413872866772
169,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.174133045323605,0.804413872866772
170,WP_15Q25_COPY_NUMBER_VARIATION,27,Up,0.174664165608973,0.804413872866772
171,WP_BENZOAPYRENE_METABOLISM,5,Up,0.175048060816364,0.804413872866772
172,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,21,Down,0.175211947895139,0.804413872866772
173,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.175728586572874,0.804413872866772
174,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.176380087480874,0.804413872866772
175,WP_KREBS_CYCLE_DISORDERS,11,Down,0.177249856832263,0.804413872866772
176,WP_MESODERMAL_COMMITMENT_PATHWAY,76,Up,0.177268897569479,0.804413872866772
177,WP_CYTOSOLIC_DNASENSING_PATHWAY,54,Down,0.177286641385779,0.804413872866772
178,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.177671850250642,0.804413872866772
179,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.177700772832658,0.804413872866772
180,WP_DISORDERS_IN_KETOLYSIS,3,Down,0.179602734218897,0.804413872866772
181,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.179788240050571,0.804413872866772
182,WP_RETINOL_METABOLISM,6,Down,0.181426360986847,0.804413872866772
183,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,44,Up,0.183589840869162,0.804413872866772
184,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,19,Down,0.184103042213605,0.804413872866772
185,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,60,Up,0.184153547667848,0.804413872866772
186,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.18440010036207,0.804413872866772
187,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Down,0.184607405826481,0.804413872866772
188,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,0.186311213073221,0.804413872866772
189,WP_BREAST_CANCER_PATHWAY,87,Up,0.189710440819463,0.804413872866772
190,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.190788028553975,0.804413872866772
191,WP_G13_SIGNALING,29,Down,0.191938152882082,0.804413872866772
192,WP_IL18_SIGNALING,193,Down,0.192449772314095,0.804413872866772
193,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.192753041611002,0.804413872866772
194,WP_HUNGER_AND_SATIETY,2,Down,0.195281399436448,0.804413872866772
195,WP_ATR_SIGNALING,10,Up,0.19537968785109,0.804413872866772
196,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.195623048042999,0.804413872866772
197,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Down,0.196464945239482,0.804413872866772
198,WP_TRANSLATION_FACTORS,49,Down,0.200883043284615,0.804413872866772
199,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.201687507346289,0.804413872866772
200,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.202119738671853,0.804413872866772
201,WP_AGERAGE_PATHWAY,54,Down,0.202662047020809,0.804413872866772
202,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Up,0.203267441447581,0.804413872866772
203,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Up,0.203791160887845,0.804413872866772
204,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.2047221247583,0.804413872866772
205,WP_TCELL_RECEPTOR_SIGNALING,73,Down,0.205329040689668,0.804413872866772
206,WP_KALLMANN_SYNDROME,11,Up,0.20547085953192,0.804413872866772
207,WP_VEGFAVEGFR2_SIGNALING,341,Down,0.205712480404595,0.804413872866772
208,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.206105225546428,0.804413872866772
209,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.206435246683189,0.804413872866772
210,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Down,0.206447162110441,0.804413872866772
211,WP_RETT_SYNDROME,30,Down,0.207239035357171,0.804413872866772
212,WP_COMPLEMENT_SYSTEM,52,Up,0.207464405167586,0.804413872866772
213,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,58,Down,0.209949215583637,0.808248422017327
214,WP_FOCAL_ADHESION,118,Down,0.211261445676975,0.808248422017327
215,WP_NRF2ARE_REGULATION,20,Down,0.211403176075092,0.808248422017327
216,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.21527146451402,0.815723980108295
217,WP_PYRIMIDINE_METABOLISM,71,Up,0.215564903198244,0.815723980108295
218,WP_OSTEOCLAST_SIGNALING,9,Up,0.21710986827842,0.815723980108295
219,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Down,0.217772028711841,0.815723980108295
220,WP_LUNG_FIBROSIS,34,Down,0.218320286646989,0.815723980108295
221,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,16,Down,0.220346508597323,0.819569366819003
222,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,23,Down,0.222382667707151,0.82246359658074
223,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Up,0.22408237939903,0.82246359658074
224,WP_ACUTE_VIRAL_MYOCARDITIS,67,Down,0.224126332888182,0.82246359658074
225,WP_ENERGY_METABOLISM,41,Down,0.226514185729204,0.82399346244362
226,WP_GLYCOLYSIS_IN_SENESCENCE,10,Down,0.231663362484678,0.82399346244362
227,WP_WNT_SIGNALING_WP428,60,Up,0.232118090830042,0.82399346244362
228,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.232714495189114,0.82399346244362
229,WP_DNA_REPLICATION,35,Up,0.234151968021016,0.82399346244362
230,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.235377322243043,0.82399346244362
231,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,5,Up,0.235684007855102,0.82399346244362
232,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.236616725252682,0.82399346244362
233,WP_GASTRIN_SIGNALING,92,Down,0.237734361707241,0.82399346244362
234,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.238044703317978,0.82399346244362
235,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Down,0.238221814852767,0.82399346244362
236,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.238407185468949,0.82399346244362
237,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Down,0.238844925763141,0.82399346244362
238,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Down,0.239458904395811,0.82399346244362
239,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Down,0.239579607693461,0.82399346244362
240,WP_ASPIRIN_AND_MIRNAS,8,Up,0.244033894713222,0.827919413117936
241,WP_PURINE_METABOLISM,10,Up,0.244446239506574,0.827919413117936
242,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.245103813999809,0.827919413117936
243,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,18,Up,0.246529154541653,0.827919413117936
244,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.246599260816245,0.827919413117936
245,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Down,0.247466980691002,0.827919413117936
246,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.248947333471912,0.827919413117936
247,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.250557426024532,0.827919413117936
248,WP_VITAMIN_B12_DISORDERS,9,Down,0.252131111851297,0.827919413117936
249,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Down,0.255250663143473,0.827919413117936
250,WP_CHOLESTEROL_METABOLISM,52,Up,0.255804955132303,0.827919413117936
251,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.257002297701383,0.827919413117936
252,WP_ULCERATIVE_COLITIS_SIGNALING,13,Up,0.257537978572736,0.827919413117936
253,WP_CELL_CYCLE,95,Up,0.257717208602354,0.827919413117936
254,WP_OSTEOPONTIN_SIGNALING,11,Down,0.257737275728882,0.827919413117936
255,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,88,Up,0.258570359407514,0.827919413117936
256,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.259500601099219,0.827919413117936
257,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Down,0.259889779044916,0.827919413117936
258,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.260458398700013,0.827919413117936
259,WP_REGULATION_OF_ACTIN_CYTOSKELETON,89,Down,0.261924481619337,0.827919413117936
260,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.262398062938884,0.827919413117936
261,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,13,Down,0.263520768739142,0.827919413117936
262,WP_ADIPOGENESIS,87,Down,0.263886722915936,0.827919413117936
263,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.265495144606442,0.829798512800363
264,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Up,0.269416922182009,0.834681243833893
265,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.272597151092986,0.834681243833893
266,WP_APOPTOSIS_MODULATION_AND_SIGNALING,78,Down,0.273697556192066,0.834681243833893
267,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Up,0.276950907714104,0.834681243833893
268,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.277296576288517,0.834681243833893
269,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,8,Up,0.277478296321798,0.834681243833893
270,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.27833964369159,0.834681243833893
271,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,11,Down,0.279474526991645,0.834681243833893
272,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.27993966651785,0.834681243833893
273,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.28225462674353,0.834681243833893
274,WP_NUCLEAR_RECEPTORS,20,Down,0.282317778179513,0.834681243833893
275,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.282452277792004,0.834681243833893
276,WP_ONECARBON_METABOLISM,22,Up,0.284666605520379,0.834681243833893
277,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,60,Up,0.286887299231051,0.834681243833893
278,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.287237999090456,0.834681243833893
279,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Down,0.287254032235626,0.834681243833893
280,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.287822614774311,0.834681243833893
281,WP_TAMOXIFEN_METABOLISM,2,Up,0.287936676221521,0.834681243833893
282,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Up,0.289828084718705,0.834681243833893
283,WP_HEPATITIS_B_INFECTION,116,Down,0.290081064873236,0.834681243833893
284,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Down,0.290663729161868,0.834681243833893
285,WP_PRION_DISEASE_PATHWAY,28,Up,0.291186613829731,0.834681243833893
286,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Up,0.291873845103057,0.834681243833893
287,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.293085504374967,0.834681243833893
288,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.293109667184904,0.834681243833893
289,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Up,0.294100038709713,0.834681243833893
290,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Down,0.294473918140911,0.834681243833893
291,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.299874279680348,0.838223435026922
292,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.300041709557338,0.838223435026922
293,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,10,Down,0.300746472957257,0.838223435026922
294,WP_GPR40_PATHWAY,8,Down,0.301193936207647,0.838223435026922
295,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.302321007867454,0.838223435026922
296,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Down,0.302445516471699,0.838223435026922
297,WP_SEROTONIN_AND_ANXIETY,6,Down,0.304868853260213,0.838223435026922
298,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Down,0.305795553926883,0.838223435026922
299,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Up,0.307263367230588,0.838223435026922
300,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.308350310529821,0.838223435026922
301,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,0.310224236073678,0.838223435026922
302,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.310846718379622,0.838223435026922
303,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.310917383298999,0.838223435026922
304,WP_LEPTININSULIN_SIGNALING_OVERLAP,12,Up,0.313835239327347,0.838223435026922
305,WP_MTHFR_DEFICIENCY,18,Up,0.314195207392759,0.838223435026922
306,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.315834926823916,0.838223435026922
307,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,63,Down,0.315989698963969,0.838223435026922
308,WP_TP53_NETWORK,16,Up,0.31632005913884,0.838223435026922
309,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.316389356858189,0.838223435026922
310,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.317905304223056,0.838223435026922
311,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.317965562129468,0.838223435026922
312,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.318157800156204,0.838223435026922
313,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Down,0.32168190263836,0.844269575565971
314,WP_DNA_DAMAGE_RESPONSE,59,Up,0.323464241150854,0.844269575565971
315,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Down,0.323533961439515,0.844269575565971
316,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.324702679173469,0.844637981900605
317,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.328238583399976,0.845392250363461
318,WP_RETINOBLASTOMA_GENE_IN_CANCER,71,Up,0.328579498154572,0.845392250363461
319,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Down,0.328641647303299,0.845392250363461
320,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,16,Up,0.329106472160958,0.845392250363461
321,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.330287974045122,0.845784157835173
322,WP_GLYOXYLATE_METABOLISM,5,Down,0.331731768508291,0.846843210291352
323,WP_MELATONIN_METABOLISM_AND_EFFECTS,20,Up,0.339491934548183,0.862167085182023
324,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.340282450986405,0.862167085182023
325,WP_BENZENE_METABOLISM,3,Down,0.34088114681771,0.862167085182023
326,WP_OSTEOBLAST_SIGNALING,3,Up,0.343478421468143,0.864016241262437
327,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Down,0.343714490137247,0.864016241262437
328,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,52,Up,0.345451714971863,0.864597699139945
329,WP_TAR_SYNDROME,44,Down,0.346049444059662,0.864597699139945
330,WP_ECTODERM_DIFFERENTIATION,77,Up,0.350387196496295,0.872782653090772
331,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Down,0.352634332254596,0.873053480433195
332,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,63,Down,0.353134945886544,0.873053480433195
333,WP_IL26_SIGNALING,33,Down,0.354090738458286,0.873053480433195
334,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.35558811891778,0.873053480433195
335,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Down,0.355806467086521,0.873053480433195
336,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.357123153630275,0.873676286559779
337,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Up,0.358249254926525,0.873830526853423
338,WP_PRIMARY_OVARIAN_INSUFFICIENCY,91,Up,0.359623879536473,0.874588251417103
339,WP_OVARIAN_INFERTILITY,21,Up,0.360877764176429,0.874621140885773
340,WP_ID_SIGNALING,12,Up,0.361765435402874,0.874621140885773
341,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,90,Down,0.364080972990965,0.877638005274408
342,WP_ARYLAMINE_METABOLISM,1,Up,0.366280303646241,0.879490652167175
343,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Down,0.36698940838606,0.879490652167175
344,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Down,0.368501041311652,0.879607803091326
345,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,30,Down,0.369178457501834,0.879607803091326
346,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,20,Up,0.371981354370132,0.880795969699344
347,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.372793654593223,0.880795969699344
348,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Up,0.372891724398262,0.880795969699344
349,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,172,Up,0.375394452807651,0.884166877386502
350,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,44,Down,0.3780434832618,0.884334902029045
351,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,47,Down,0.379076970497723,0.884334902029045
352,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,41,Up,0.379594002472526,0.884334902029045
353,WP_16P112_DISTAL_DELETION_SYNDROME,21,Up,0.380282256672924,0.884334902029045
354,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Down,0.381367098331187,0.884334902029045
355,WP_SPINAL_CORD_INJURY,67,Down,0.381920791022276,0.884334902029045
356,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.383286694366936,0.885004670701183
357,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.384708245862469,0.885798818204341
358,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.386009461536646,0.886312227327159
359,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.388410222712254,0.888822390746232
360,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.392052764579403,0.888822390746232
361,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.39648455758821,0.888822390746232
362,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,76,Up,0.39938568141389,0.888822390746232
363,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.400886338584777,0.888822390746232
364,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.401599598926296,0.888822390746232
365,WP_SERINE_METABOLISM,5,Up,0.402182608266692,0.888822390746232
366,WP_THERMOGENESIS,73,Down,0.402407815292072,0.888822390746232
367,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Up,0.402587919487087,0.888822390746232
368,WP_POSTCOVID_NEUROINFLAMMATION,13,Down,0.402989460561035,0.888822390746232
369,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.404017538226692,0.888822390746232
370,WP_MELANOMA,54,Up,0.404165448693938,0.888822390746232
371,WP_TGFB_SMAD_SIGNALING,8,Down,0.404509456522992,0.888822390746232
372,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.406603572158055,0.888822390746232
373,WP_ALLOGRAFT_REJECTION,52,Up,0.408168214108298,0.888822390746232
374,WP_PDGF_PATHWAY,36,Down,0.408957700102682,0.888822390746232
375,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Down,0.409282296284427,0.888822390746232
376,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.410770232153553,0.888822390746232
377,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Up,0.411878784889949,0.888822390746232
378,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.412190299327978,0.888822390746232
379,WP_SPHINGOLIPID_PATHWAY,21,Down,0.412438779165984,0.888822390746232
380,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.414978988175482,0.888822390746232
381,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.414978988175482,0.888822390746232
382,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.415044863634045,0.888822390746232
383,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.415491025354229,0.888822390746232
384,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.416211058994766,0.888822390746232
385,WP_IL7_SIGNALING,23,Up,0.41629759177287,0.888822390746232
386,WP_HEART_DEVELOPMENT,16,Up,0.418994514040458,0.892262928863358
387,WP_ENDOMETRIAL_CANCER,48,Up,0.420755488389468,0.89369770402104
388,WP_NOTCH_SIGNALING_WP61,49,Down,0.424997455240468,0.899260452945336
389,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,19,Up,0.428655213050727,0.899260452945336
390,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.429265953424538,0.899260452945336
391,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Up,0.429868550213265,0.899260452945336
392,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,74,Down,0.431008500208255,0.899260452945336
393,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,44,Down,0.432491601280936,0.899260452945336
394,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.432894002988165,0.899260452945336
395,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,10,Up,0.434001108921603,0.899260452945336
396,WP_GPCRS_CLASS_A_RHODOPSINLIKE,44,Down,0.434146352454375,0.899260452945336
397,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.434314355011312,0.899260452945336
398,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Down,0.442649023918301,0.910099905222175
399,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.442717968633535,0.910099905222175
400,WP_TRYPTOPHAN_METABOLISM,19,Down,0.444312283454776,0.910099905222175
401,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.44544722968701,0.910099905222175
402,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.445613782172181,0.910099905222175
403,WP_VITAMIN_D_RECEPTOR_PATHWAY,84,Down,0.446358773311108,0.910099905222175
404,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,50,Up,0.447772387057682,0.910099905222175
405,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.448791571404056,0.910099905222175
406,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,38,Down,0.450656640651172,0.910099905222175
407,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,79,Up,0.451288056330142,0.910099905222175
408,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.452790402068762,0.910099905222175
409,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.453380662366262,0.910099905222175
410,WP_ALZHEIMERS_DISEASE,184,Down,0.455621708367386,0.910099905222175
411,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Down,0.455621708367386,0.910099905222175
412,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Down,0.457108309061187,0.910099905222175
413,WP_BARDETBIEDL_SYNDROME,65,Up,0.458905987545292,0.910099905222175
414,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Down,0.459413669182542,0.910099905222175
415,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,18,Up,0.460282668107273,0.910099905222175
416,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Up,0.463366285384981,0.910099905222175
417,WP_WNT_SIGNALING_WP363,38,Up,0.463778821816566,0.910099905222175
418,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.464651651480294,0.910099905222175
419,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Down,0.464815096520863,0.910099905222175
420,WP_ENDOCHONDRAL_OSSIFICATION,27,Up,0.46988160745662,0.910099905222175
421,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,27,Up,0.46988160745662,0.910099905222175
422,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.470055792998246,0.910099905222175
423,WP_UROTENSINIIMEDIATED_SIGNALING,50,Down,0.470460686304802,0.910099905222175
424,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Up,0.471812747183697,0.910099905222175
425,WP_B_CELL_RECEPTOR_SIGNALING,85,Down,0.472144959548613,0.910099905222175
426,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Down,0.472535800565801,0.910099905222175
427,WP_SPINA_BIFIDA,10,Up,0.472764792615412,0.910099905222175
428,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Up,0.477527424697431,0.917120427806748
429,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,71,Down,0.480399446476652,0.918546321137233
430,WP_BASE_EXCISION_REPAIR,29,Up,0.480504766531643,0.918546321137233
431,WP_MATRIX_METALLOPROTEINASES,8,Up,0.485402704498451,0.921982183791714
432,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.488433166868281,0.921982183791714
433,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Down,0.488963771743844,0.921982183791714
434,WP_DNA_MISMATCH_REPAIR,21,Up,0.489594237305804,0.921982183791714
435,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.490587586911617,0.921982183791714
436,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.490726497787189,0.921982183791714
437,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.491092579769614,0.921982183791714
438,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.493616048308469,0.921982183791714
439,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.493616048308469,0.921982183791714
440,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Down,0.494243256930701,0.921982183791714
441,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Up,0.494640076705773,0.921982183791714
442,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.496481335343882,0.923320492426857
443,WP_VITAMIN_D_METABOLISM,6,Down,0.498136428289256,0.92430732292047
444,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.500709795787185,0.9245009718545
445,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.504083692146041,0.9245009718545
446,WP_KLEEFSTRA_SYNDROME,25,Down,0.504876288394643,0.9245009718545
447,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.505444187071119,0.9245009718545
448,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Down,0.506406534263184,0.9245009718545
449,WP_INSULIN_SIGNALING,129,Down,0.507181074339943,0.9245009718545
450,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.50724014365221,0.9245009718545
451,WP_KININKALLIKREIN_PATHWAY,2,Up,0.509134873529693,0.9245009718545
452,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,18,Up,0.509196499865007,0.9245009718545
453,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.510445586530796,0.9245009718545
454,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.512638954965601,0.9245009718545
455,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,30,Down,0.51488996595199,0.9245009718545
456,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.515018507496082,0.9245009718545
457,WP_GALANIN_RECEPTOR_PATHWAY,12,Up,0.516260769353562,0.9245009718545
458,WP_SLEEP_REGULATION,11,Up,0.518408015449764,0.9245009718545
459,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.519458705516987,0.9245009718545
460,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.519814409001657,0.9245009718545
461,WP_PARKINSONS_DISEASE_PATHWAY,27,Up,0.520286967527184,0.9245009718545
462,WP_ONCOSTATIN_M_SIGNALING,56,Up,0.521345192644375,0.9245009718545
463,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.521614324885491,0.9245009718545
464,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.522134809497038,0.9245009718545
465,WP_MACROPHAGE_MARKERS,9,Down,0.524328912965889,0.9245009718545
466,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.525185968110638,0.9245009718545
467,WP_MIRNA_BIOGENESIS,6,Up,0.526040803929807,0.9245009718545
468,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,49,Down,0.526358217552197,0.9245009718545
469,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.52778413176914,0.925028904721179
470,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,12,Up,0.531509050726187,0.92911228603793
471,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Up,0.53237455805823,0.92911228603793
472,WP_ACUTE_MYELOID_LEUKEMIA,55,Up,0.534454714151521,0.929240231753877
473,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,48,Down,0.535729520221332,0.929240231753877
474,WP_MRNA_PROCESSING,124,Up,0.535839257726688,0.929240231753877
475,WP_FRAGILE_X_SYNDROME,83,Down,0.53777114065078,0.930627110768297
476,WP_INTEGRATED_CANCER_PATHWAY,40,Up,0.538961256824941,0.930727212416179
477,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,2,Down,0.542323980921857,0.933712086251802
478,WP_IL17_SIGNALING,25,Down,0.543203768554474,0.933712086251802
479,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.545918551904523,0.933712086251802
480,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Up,0.545982323443653,0.933712086251802
481,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,27,Down,0.546369237818877,0.933712086251802
482,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.549823993807617,0.934034014350022
483,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,81,Down,0.550288548010166,0.934034014350022
484,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.550639472379957,0.934034014350022
485,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.551335273196799,0.934034014350022
486,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.554684258657717,0.934034014350022
487,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.55627070929028,0.934034014350022
488,WP_PPARALPHA_PATHWAY,15,Up,0.556945958258026,0.934034014350022
489,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.557952292084142,0.934034014350022
490,WP_NEUROINFLAMMATION,10,Down,0.559313270754086,0.934034014350022
491,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,31,Down,0.559483927847144,0.934034014350022
492,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.560136157244309,0.934034014350022
493,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.560193149725743,0.934034014350022
494,WP_AEROBIC_GLYCOLYSIS,10,Down,0.566256332696835,0.937408810341712
495,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Down,0.566256332696835,0.937408810341712
496,WP_PREIMPLANTATION_EMBRYO,20,Down,0.573877530908999,0.937408810341712
497,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.575318492550987,0.937408810341712
498,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.578315863204492,0.937408810341712
499,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Down,0.580345492308868,0.937408810341712
500,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Up,0.581496832837002,0.937408810341712
501,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.582515742132873,0.937408810341712
502,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Down,0.583054050078504,0.937408810341712
503,WP_MEVALONATE_PATHWAY,7,Up,0.584100861584842,0.937408810341712
504,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Up,0.586032268177081,0.937408810341712
505,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.586963015936933,0.937408810341712
506,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,11,Down,0.589279457097024,0.937408810341712
507,WP_BDNFTRKB_SIGNALING,26,Up,0.58958042385551,0.937408810341712
508,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.589596726061813,0.937408810341712
509,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,83,Down,0.591178113924918,0.937408810341712
510,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Down,0.591531750004584,0.937408810341712
511,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Down,0.591957936655042,0.937408810341712
512,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.593062385926277,0.937408810341712
513,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.59325519841006,0.937408810341712
514,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Up,0.593504853818715,0.937408810341712
515,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,71,Up,0.593723262511205,0.937408810341712
516,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.594290584139943,0.937408810341712
517,WP_PROTEASOME_DEGRADATION,57,Up,0.597018686023178,0.937408810341712
518,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.598390858643103,0.937408810341712
519,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.59848534777945,0.937408810341712
520,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.598673308656571,0.937408810341712
521,WP_ENDODERM_DIFFERENTIATION,82,Up,0.599901391577961,0.937408810341712
522,WP_TGFBETA_RECEPTOR_SIGNALING,35,Down,0.600439861959532,0.937408810341712
523,WP_STEROID_BIOSYNTHESIS,2,Down,0.60151028570264,0.937408810341712
524,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.602236876484839,0.937408810341712
525,WP_DOPAMINE_METABOLISM,7,Down,0.603690755204824,0.937408810341712
526,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.60369500562112,0.937408810341712
527,WP_PANCREATIC_CANCER_SUBTYPES,5,Down,0.60458587012274,0.937408810341712
528,WP_EBOLA_VIRUS_INFECTION_IN_HOST,106,Down,0.605147974156202,0.937408810341712
529,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,142,Down,0.607334209761429,0.937408810341712
530,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.608305653307983,0.937408810341712
531,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.609205623802378,0.937408810341712
532,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.610063241489234,0.937408810341712
533,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.610595376493793,0.937408810341712
534,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.610952817785797,0.937408810341712
535,WP_P38_MAPK_SIGNALING,31,Down,0.612111871909352,0.937408810341712
536,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,31,Down,0.612774329308653,0.937408810341712
537,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Down,0.613225800909067,0.937408810341712
538,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Down,0.613535206768663,0.937408810341712
539,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.614742780109843,0.937511252783471
540,WP_APOPTOSIS,72,Down,0.618544381436547,0.941562002853411
541,WP_MONOAMINE_TRANSPORT,12,Down,0.6229450302876,0.944551750952169
542,WP_SELENIUM_MICRONUTRIENT_NETWORK,53,Up,0.623915390033249,0.944551750952169
543,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Up,0.624326581621979,0.944551750952169
544,WP_LUNG_PATHOLOGY_OF_COVID19,16,Down,0.62594960309283,0.944551750952169
545,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.6276649308365,0.944551750952169
546,WP_HEDGEHOG_SIGNALING_WP4249,24,Down,0.627695371958878,0.944551750952169
547,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.631320337231024,0.944551750952169
548,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Down,0.63137170155198,0.944551750952169
549,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.631872584525196,0.944551750952169
550,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.631999346744152,0.944551750952169
551,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,64,Up,0.63342930045032,0.944970753121893
552,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Up,0.635507251715278,0.945924062494885
553,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,37,Up,0.637543319735966,0.945924062494885
554,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.638829930021466,0.945924062494885
555,WP_GLIOBLASTOMA_SIGNALING,68,Up,0.638972384854086,0.945924062494885
556,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.640697218467987,0.945924062494885
557,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.641395503122383,0.945924062494885
558,WP_JOUBERT_SYNDROME,70,Down,0.642307373153466,0.945924062494885
559,WP_LEPTIN_SIGNALING,69,Down,0.644922440174448,0.945924062494885
560,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.64612132613381,0.945924062494885
561,WP_IL9_SIGNALING,15,Up,0.648075417729913,0.945924062494885
562,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Up,0.648083421450948,0.945924062494885
563,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.649094615574487,0.945924062494885
564,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.650893147763886,0.945924062494885
565,WP_OMEGA9_FATTY_ACID_SYNTHESIS,10,Up,0.651357165142176,0.945924062494885
566,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Down,0.652635135989246,0.945924062494885
567,WP_NUCLEAR_RECEPTORS_METAPATHWAY,179,Down,0.653986727274777,0.945924062494885
568,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Down,0.654858549412349,0.945924062494885
569,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.65502456544829,0.945924062494885
570,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,11,Up,0.655932744065796,0.945924062494885
571,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Up,0.661164932737476,0.950811562280552
572,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.663669035626944,0.950811562280552
573,WP_CILIOPATHIES,127,Down,0.663750476998646,0.950811562280552
574,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,46,Down,0.66409691997259,0.950811562280552
575,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.665105411570946,0.950811562280552
576,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.667349388817792,0.952284373162769
577,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,48,Down,0.669132846549576,0.952284373162769
578,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.671380677647073,0.952284373162769
579,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,16,Down,0.672674568541048,0.952284373162769
580,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.672957261556279,0.952284373162769
581,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,61,Up,0.673404167667132,0.952284373162769
582,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.67432590672349,0.952284373162769
583,WP_GLUCURONIDATION,7,Down,0.675403636926879,0.952284373162769
584,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,19,Down,0.681546776381601,0.957981372312955
585,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,272,Up,0.681775064237322,0.957981372312955
586,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,168,Up,0.685367369906593,0.961385628094231
587,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.688795865183076,0.962386170395062
588,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Up,0.688995970159048,0.962386170395062
589,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,59,Up,0.690216159580255,0.962386170395062
590,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.694708443238196,0.962386170395062
591,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.6956195788685,0.962386170395062
592,WP_GPCRS_OTHER,14,Down,0.69708613711142,0.962386170395062
593,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,85,Up,0.69773305589874,0.962386170395062
594,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Up,0.699115322663545,0.962386170395062
595,WP_PHOSPHOINOSITIDES_METABOLISM,38,Up,0.69964711069914,0.962386170395062
596,WP_NAD_METABOLISM,12,Down,0.701332002170598,0.962386170395062
597,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,19,Down,0.701914836126072,0.962386170395062
598,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,22,Down,0.702451889235242,0.962386170395062
599,WP_PPAR_SIGNALING,39,Down,0.704129985343873,0.962386170395062
600,WP_METHYLATION_PATHWAYS,5,Down,0.70727005359715,0.962386170395062
601,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,22,Down,0.708617888705893,0.962386170395062
602,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,57,Up,0.709296230493213,0.962386170395062
603,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,62,Up,0.709756033726819,0.962386170395062
604,WP_AMINO_ACID_METABOLISM,59,Up,0.711728878893327,0.962386170395062
605,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.712605400750306,0.962386170395062
606,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,96,Down,0.713776696104205,0.962386170395062
607,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.713943362128551,0.962386170395062
608,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.714053788605748,0.962386170395062
609,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.715073669717975,0.962386170395062
610,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.715347934430349,0.962386170395062
611,WP_IL10_ANTIINFLAMMATORY_SIGNALING,12,Up,0.715350304271755,0.962386170395062
612,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.719365760491229,0.962869902812145
613,WP_INTERFERON_TYPE_I_SIGNALING,50,Up,0.720031222044041,0.962869902812145
614,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.720652548015506,0.962869902812145
615,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.721224397585148,0.962869902812145
616,WP_GABA_RECEPTOR_SIGNALING,9,Up,0.721566739820294,0.962869902812145
617,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Up,0.724957870755452,0.963437776754572
618,WP_IL11_SIGNALING,40,Down,0.727034321806491,0.963437776754572
619,WP_PEPTIDE_GPCRS,15,Down,0.728559316570907,0.963437776754572
620,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.729889489201034,0.963437776754572
621,WP_SMALL_LIGAND_GPCRS,7,Up,0.732304063385896,0.963437776754572
622,WP_RAS_SIGNALING,116,Down,0.733905607238229,0.963437776754572
623,WP_CANCER_PATHWAYS,308,Up,0.735949069035396,0.963437776754572
624,WP_GASTRIC_CANCER_NETWORK_1,18,Down,0.736081225174835,0.963437776754572
625,WP_ACETYLCHOLINE_SYNTHESIS,4,Up,0.73641061102727,0.963437776754572
626,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.736987766429425,0.963437776754572
627,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.737718518777098,0.963437776754572
628,WP_EGFEGFR_SIGNALING,138,Down,0.738261545964998,0.963437776754572
629,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.739399646085195,0.963437776754572
630,WP_NETRINUNC5B_SIGNALING,36,Up,0.739786301368907,0.963437776754572
631,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,30,Down,0.740763016774723,0.963437776754572
632,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.74248133268915,0.963437776754572
633,WP_ENDOTHELIN_PATHWAYS,13,Up,0.743152350828313,0.963437776754572
634,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Down,0.745432165387562,0.963437776754572
635,WP_BURN_WOUND_HEALING,60,Down,0.745695265331966,0.963437776754572
636,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,51,Up,0.747737742129882,0.963437776754572
637,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,87,Up,0.748329791811566,0.963437776754572
638,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.748786918739024,0.963437776754572
639,WP_PROLACTIN_SIGNALING,69,Down,0.748949804557387,0.963437776754572
640,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,67,Up,0.75089352626252,0.964428872793425
641,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Down,0.753317911149577,0.964921730257277
642,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.755048647993488,0.964921730257277
643,WP_SILDENAFIL_TREATMENT,11,Down,0.756194633242714,0.964921730257277
644,WP_NONSMALL_CELL_LUNG_CANCER,59,Up,0.756471177001755,0.964921730257277
645,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Up,0.758222459153492,0.964921730257277
646,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Up,0.761054512441843,0.964921730257277
647,WP_GASTRIC_CANCER_NETWORK_2,26,Up,0.762282936727859,0.964921730257277
648,WP_IL6_SIGNALING,40,Up,0.762925209698563,0.964921730257277
649,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,10,Down,0.763306932808165,0.964921730257277
650,WP_HIPPOYAP_SIGNALING,16,Down,0.766468237649022,0.964921730257277
651,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.767317548982524,0.964921730257277
652,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.768597753449557,0.964921730257277
653,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Down,0.768682023079422,0.964921730257277
654,WP_HYPERTROPHY_MODEL,14,Up,0.769789691664764,0.964921730257277
655,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.770113528806916,0.964921730257277
656,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Down,0.770123355502768,0.964921730257277
657,WP_TCELL_ACTIVATION_SARSCOV2,61,Down,0.771239689016409,0.964921730257277
658,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.772406932493051,0.964921730257277
659,WP_15Q11Q13_COPY_NUMBER_VARIATION,31,Down,0.776692618148753,0.967856834139158
660,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.777111326681076,0.967856834139158
661,WP_KCNQ2RELATED_EPILEPSIES,12,Down,0.779643799308236,0.968626150511953
662,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.781973783936993,0.968626150511953
663,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,33,Up,0.78629786749341,0.968626150511953
664,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.786399227656809,0.968626150511953
665,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.786399227656809,0.968626150511953
666,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.786700231173569,0.968626150511953
667,WP_CAMKK2_PATHWAY,29,Down,0.78698649978109,0.968626150511953
668,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Down,0.787156044454969,0.968626150511953
669,WP_SMALL_CELL_LUNG_CANCER,71,Down,0.789115336545166,0.969508042631457
670,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,51,Up,0.791398043440774,0.969508042631457
671,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.791411066430301,0.969508042631457
672,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.793919171500256,0.971133272281564
673,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.797300688591841,0.973328177009739
674,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Up,0.798081741246428,0.973328177009739
675,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.801604407760439,0.976176034339379
676,WP_KETOGENESIS_AND_KETOLYSIS,5,Down,0.80810099416565,0.97673139622529
677,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.809203968288363,0.97673139622529
678,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.810004224940438,0.97673139622529
679,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.811777437342716,0.97673139622529
680,WP_AXON_GUIDANCE,37,Up,0.81197036306266,0.97673139622529
681,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.815735259921612,0.97673139622529
682,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Up,0.815891782451779,0.97673139622529
683,WP_ACE_INHIBITOR_PATHWAY,3,Down,0.816870115633464,0.97673139622529
684,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.818155792845448,0.97673139622529
685,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Up,0.819809208860351,0.97673139622529
686,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Up,0.821356280758431,0.97673139622529
687,WP_ALSTROM_SYNDROME,27,Up,0.822914409398391,0.97673139622529
688,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Up,0.823071970651856,0.97673139622529
689,WP_HISTONE_MODIFICATIONS,37,Down,0.823424969063342,0.97673139622529
690,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Down,0.824909051763946,0.97673139622529
691,WP_CORI_CYCLE,11,Down,0.827664944091679,0.97673139622529
692,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.829331368533517,0.97673139622529
693,WP_PDGFRBETA_PATHWAY,27,Down,0.829571897720403,0.97673139622529
694,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.82989058542124,0.97673139622529
695,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,21,Down,0.830267039218418,0.97673139622529
696,WP_GLUTATHIONE_METABOLISM,10,Down,0.830313376194388,0.97673139622529
697,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,79,Down,0.83147175727808,0.97673139622529
698,WP_FATTY_ACID_BETAOXIDATION,29,Down,0.833352893529394,0.97673139622529
699,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Up,0.83667948026828,0.97673139622529
700,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.837043559112946,0.97673139622529
701,WP_FOLATE_METABOLISM,40,Up,0.837188428684253,0.97673139622529
702,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,78,Up,0.83748707081661,0.97673139622529
703,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Up,0.838267692510841,0.97673139622529
704,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.838505572689459,0.97673139622529
705,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Down,0.838719651401872,0.97673139622529
706,WP_IL4_SIGNALING,50,Down,0.839830112562366,0.97673139622529
707,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Down,0.84133989396419,0.97673139622529
708,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,66,Up,0.84284411750342,0.97673139622529
709,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,14,Up,0.844370889386566,0.97673139622529
710,WP_G_PROTEIN_SIGNALING,61,Up,0.844887354595294,0.97673139622529
711,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.845544000146773,0.97673139622529
712,WP_FOXP3_IN_COVID19,10,Up,0.846463908868403,0.97673139622529
713,WP_IL5_SIGNALING,37,Down,0.847213486020233,0.97673139622529
714,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Down,0.849337084486568,0.977808240123191
715,WP_EICOSANOID_SYNTHESIS,13,Up,0.851642736134611,0.97790772917707
716,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Down,0.852384185135697,0.97790772917707
717,WP_IRINOTECAN_PATHWAY,5,Down,0.853131120126178,0.97790772917707
718,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,27,Up,0.856223613851462,0.97790772917707
719,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Up,0.858489094123585,0.97790772917707
720,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Down,0.860600467458071,0.97790772917707
721,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,17,Up,0.860692147630166,0.97790772917707
722,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Up,0.860894342240182,0.97790772917707
723,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.862471150063026,0.97790772917707
724,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.863676576802525,0.97790772917707
725,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,25,Up,0.864584050132259,0.97790772917707
726,WP_NEPHROTIC_SYNDROME,28,Up,0.864932093122794,0.97790772917707
727,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Down,0.866396922758325,0.97790772917707
728,WP_VITAMIN_B12_METABOLISM,27,Down,0.867682861027626,0.97790772917707
729,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.869073031701678,0.97790772917707
730,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Down,0.869420634468264,0.97790772917707
731,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Up,0.869907899472935,0.97790772917707
732,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.87481311918215,0.97790772917707
733,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.875201345530431,0.97790772917707
734,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.877262639468359,0.97790772917707
735,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Up,0.878051116230645,0.97790772917707
736,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.879405578661862,0.97790772917707
737,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.88092507799347,0.97790772917707
738,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.881625201877475,0.97790772917707
739,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Down,0.881829813563007,0.97790772917707
740,WP_FOXA2_PATHWAY,9,Up,0.88258947451217,0.97790772917707
741,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.882779493487482,0.97790772917707
742,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.885931873407883,0.97790772917707
743,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.885979095680636,0.97790772917707
744,WP_CILIARY_LANDSCAPE,184,Down,0.888566057781061,0.97790772917707
745,WP_AUTOPHAGY,27,Up,0.888803259018181,0.97790772917707
746,WP_METABOLIC_EPILEPTIC_DISORDERS,56,Down,0.890346582469352,0.97790772917707
747,WP_NEOVASCULARIZATION_PROCESSES,22,Down,0.890530345188222,0.97790772917707
748,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,41,Down,0.893799815127313,0.97790772917707
749,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.894189728333708,0.97790772917707
750,WP_CHOLESTASIS,9,Down,0.894288473651531,0.97790772917707
751,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Up,0.895792360905809,0.97790772917707
752,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.897043124535369,0.97790772917707
753,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,23,Down,0.897681716406085,0.97790772917707
754,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.897841597943933,0.97790772917707
755,WP_ERBB_SIGNALING,67,Down,0.898685970624441,0.97790772917707
756,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.899444249470254,0.97790772917707
757,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.902296127564544,0.97790772917707
758,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.902659457032733,0.97790772917707
759,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Down,0.904083373057194,0.97790772917707
760,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.904148265419189,0.97790772917707
761,WP_PI3KAKT_SIGNALING,180,Up,0.905586293717889,0.978175996630887
762,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,16,Down,0.908991975973269,0.979075686765765
763,WP_IL19_SIGNALING,20,Down,0.909748348589356,0.979075686765765
764,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.910038957068815,0.979075686765765
765,WP_CELLULAR_PROTEOSTASIS,6,Up,0.911183577099526,0.979075686765765
766,WP_TRANSSULFURATION_PATHWAY,8,Up,0.914933930094504,0.979322410527921
767,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,68,Down,0.916228999380368,0.979322410527921
768,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.917211685343962,0.979322410527921
769,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,27,Up,0.917975334235465,0.979322410527921
770,WP_IL2_SIGNALING,37,Down,0.918659469198528,0.979322410527921
771,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,63,Down,0.92051201402362,0.979322410527921
772,WP_COPPER_HOMEOSTASIS,40,Up,0.921211902484933,0.979322410527921
773,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.923716409071458,0.979322410527921
774,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,127,Up,0.924134897751431,0.979322410527921
775,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Down,0.924753879379302,0.979322410527921
776,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Down,0.925907184778726,0.979322410527921
777,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,72,Down,0.926423182009641,0.979322410527921
778,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.926901259599419,0.979322410527921
779,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.929020234252657,0.979412376878101
780,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Down,0.929633469056007,0.979412376878101
781,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.93056090795839,0.979412376878101
782,WP_PLEURAL_MESOTHELIOMA,257,Down,0.933041731724968,0.979777070346773
783,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Up,0.934029102995169,0.979777070346773
784,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,48,Down,0.934483239844124,0.979777070346773
785,WP_CELL_DIFFERENTIATION_INDEX,7,Up,0.937120614325494,0.98129063054211
786,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Up,0.944158344735812,0.986833845261324
787,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Up,0.944815372531219,0.986833845261324
788,WP_HIPPO_SIGNALING_REGULATION,45,Up,0.94877087281251,0.987459173041118
789,WP_KIT_RECEPTOR_SIGNALING,51,Up,0.950161947331018,0.987459173041118
790,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Down,0.951170281205462,0.987459173041118
791,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.951941586217945,0.987459173041118
792,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,10,Up,0.952047212661544,0.987459173041118
793,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.953476029162335,0.987459173041118
794,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,84,Down,0.955106917345238,0.987459173041118
795,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Up,0.955539573910164,0.987459173041118
796,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.956547111356883,0.987459173041118
797,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,0.957962686424001,0.987459173041118
798,WP_BLADDER_CANCER,29,Down,0.958660693945973,0.987459173041118
799,WP_NRF2_PATHWAY,73,Up,0.959829536812474,0.987459173041118
800,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,7,Down,0.961252562722459,0.987650938446079
801,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.965375112290398,0.987650938446079
802,WP_CIRCADIAN_RHYTHM_GENES,121,Down,0.965998092275068,0.987650938446079
803,WP_COMPLEMENT_AND_COAGULATION_CASCADES,27,Down,0.969214862580547,0.987650938446079
804,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,27,Down,0.969214862580547,0.987650938446079
805,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.970876120536987,0.987650938446079
806,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,29,Up,0.971117121268303,0.987650938446079
807,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.972033858231206,0.987650938446079
808,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Up,0.973179942146934,0.987650938446079
809,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Down,0.97343097808497,0.987650938446079
810,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Up,0.975403915765815,0.987650938446079
811,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.975535176390775,0.987650938446079
812,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.975635720216808,0.987650938446079
813,WP_MAPK_CASCADE,30,Up,0.977708291643577,0.987779454751663
814,WP_SYNAPTIC_VESICLE_PATHWAY,20,Down,0.978728750033961,0.987779454751663
815,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.97936770757008,0.987779454751663
816,WP_ESTROGEN_SIGNALING,21,Down,0.981585051876484,0.988802589022634
817,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Up,0.986621462754336,0.992659537801792
818,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.987912383098441,0.992743250497455
819,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.997285657784966,0.999612559999013
820,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.999000302546101,0.999612559999013
821,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,43,Down,0.999120607444667,0.999612559999013
822,WP_ATM_SIGNALING,34,Down,0.999612559999013,0.999612559999013
